Rode Kruis Ziekenhuis B.V.

At Rode Kruis Ziekenhuis B.V., a major share of the research focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, peripheral arterial disease, and prevention of stroke and myocardial infarction. These studies are designed to test new treatments and compare them with current care to better reduce serious heart and blood vessel complications.

• Prevention of major cardiovascular events in high-risk patients
• Treatment strategies for atrial fibrillation and stroke prevention
• Therapies for heart failure, obesity, and vascular disease
• Improving lipid-lowering approaches for cardiovascular risk reduction

Overall, the cardiology department in Beverwijk is contributing to research that aims to make cardiovascular care safer, more effective, and better tailored to patients at elevated risk.

This site is also involved in studies across neoplasms and hemic and lymphatic diseases, including breast cancer, triple negative breast cancer, metastatic colorectal cancer, multiple myeloma, and prostate cancer. The research is centered on evaluating treatment effectiveness, refining treatment sequences, and exploring ways to reduce toxicity while preserving cancer control.

• New approaches for breast cancer and triple negative breast cancer
• Optimizing treatment plans in metastatic colorectal cancer and multiple myeloma
• Testing whether treatment breaks or modified strategies can maintain control in prostate cancer
• Assessing cancer-associated clotting prevention in patients with venous thromboembolism

These trials reflect a broad oncology portfolio that seeks to improve outcomes while making therapy more manageable for patients.

Another important research area at Rode Kruis Ziekenhuis B.V. involves skin and connective tissue diseases and therapeutic techniques and equipment, with studies in burn injury, full-thickness skin defects, and complex wound healing. These trials are evaluating new skin graft products and wound treatments to improve closure, reduce scarring, and support recovery after severe injuries.

• New skin graft options for adults and children with burns or large skin defects
• Improving wound closure and scar quality after grafting
• Reducing blood loss during burn surgery
• Testing better surgical support for complex burn care

The focus is on practical innovations that could make reconstructive and burn treatment more effective for both children and adults.

The site conducts clinical research in digestive system diseases, nutritional and metabolic diseases, and hormonal diseases, including appendicitis, obesity, type 2 diabetes, and secondary hyperparathyroidism. These studies aim to improve postoperative recovery, support weight management, and assess treatments that may better control metabolic complications.

• Preventing complications after surgery for complicated appendicitis
• Supporting weight loss after bariatric surgery in patients who respond poorly
• Testing hormone-related treatment after gastric bypass surgery
• Evaluating new options for diabetes, obesity, and related cardiovascular risk

This research brings together surgical, metabolic, and endocrine care with the goal of improving long-term patient outcomes.

Research in female urogenital diseases and pregnancy complications and male urogenital diseases includes studies of placenta previa, preterm birth, and low-volume metastatic castration-sensitive prostate cancer. The main purpose is to evaluate strategies that may improve pregnancy outcomes or help patients maintain cancer control while reducing unnecessary treatment burden.

• Preventing preterm birth in women with placenta previa
• Exploring treatment de-escalation in prostate cancer
• Balancing effectiveness and quality of life in reproductive and urologic care
• Supporting safer, more individualized treatment decisions

These studies show a focus on carefully targeted care in both maternity-related and male urologic conditions.